In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand
Christopher J. Nicolai(Metis Design Corporation (United States)), Byoung Y. Ryu(CTI BioPharma (United States)), Ryan Larson(CTI BioPharma (United States)), Mollie M. McDonnell(University of Washington), Weiliang Tang(Chinese University of Hong Kong), Alissa Brandes(Unknown), Laurie Beitz(Seattle Children's Hospital), Richard S. Mangio(CTI BioPharma (United States)), Hans‐Peter Kiem(Fred Hutch Cancer Center), Sara Cooper(CTI BioPharma (United States)), Don Parrilla(CTI BioPharma (United States)), Andrew M. Scharenberg(CTI BioPharma (Italy)), Nolan G. Ericson, Maura H. Parker(CTI BioPharma (United States)), Kathryn Michels(CTI BioPharma (United States)), Justin Theophilus Ulrich-Lewis(CTI BioPharma (United States)), Saluwa Umuhoza(CTI BioPharma (United States)), Susana López(CTI BioPharma (United States)), Wai‐Hang Leung(Biogen (United States)), Seungjin Shin(Vector (United States)), L. P. Park(CTI BioPharma (United States)), Rebecca Gottschalk(Oxford Instruments (United Kingdom)), Jim Qin(Centenary Institute)
Cited by 102
Related Papers
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902